Method and system for determining a temporospatially-fractionated radiotherapy planning
US-2024424320-A1 · Dec 26, 2024 · US
US12442780B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12442780-B2 |
| Application number | US-202318454259-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 23, 2023 |
| Priority date | Aug 24, 2022 |
| Publication date | Oct 14, 2025 |
| Grant date | Oct 14, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for assessing a quality of a beam shaping device includes, establishing with a treatment planning system (TPS) the planned device design of the beam shaping device, manufacturing the beam shaping device according to the planned device design, establishing a CT-scan of the beam shaping device to yield an actual CT-image, determining dimensions and local materials densities from the actual CT-image, determining a calculated dose distribution in the treatment volume (V), and comparing the calculated dose distribution (cDD) with a reference dose distribution (rDD).
Opening claim text (preview).
The invention claimed is: 1. A method for assessing a quality of a beam shaping device manufactured according to a planned device design for shaping one or more beams of accelerated particles emitted by a particle accelerator system, the method comprising, (a) establishing with a treatment planning system (TPS) the planned device design of the beam shaping device suitable for shaping one or more beams of accelerated particles to mate a geometry of a treatment volume (V) of tissue comprising tumoral cells, for depositing specific doses (Dij) into specific locations within the treatment volume (V) thus defining a planned dose distribution (pDD) satisfying objectives on the dose deposition in the treatment volume set by a physician, (b) manufacturing the beam shaping device according to the planned device design, (c) establishing a CT-scan of the beam shaping device to yield an actual CT-image, (d) determining dimensions and local materials densities from the actual CT-image, (e) extending the actual CT-image to include the treatment volume (V), (f) determining with a dose engine a calculated dose distribution in the treatment volume (V) obtained by virtually irradiating the treatment volume (V) with the one or more beams through a virtual beam shaping device having a geometry and a density defined by the device actual CT-image, and (g) comparing the calculated dose distribution (cDD) with a reference dose distribution (rDD). 2. The method according to claim 1 , wherein the reference dose distribution (rDD) is, a calculated planned dose distribution, (cpDD) obtained by, first creating with the TPS a high-resolution planned device design corresponding to the planned device design but with a higher resolution, matching a resolution of the actual CT-image and, second, determining the calculated planned dose distribution (cpDD) with the dose engine by virtually irradiating the treatment volume (V) with the one or more beams through the high-resolution planned device, or the planned dose distribution (pDD) or a function thereof. 3. The method according to claim 2 , wherein the reference dose distribution (rDD) is either, the calculated planned dose distribution (cpDD), and wherein the high-resolution planned device design is created with a voxel size which is equal to a CT-voxel size used for establishing the actual CT-image, with a tolerance of ±20%, or the function of the planned dose distribution (pDD), which is the result of a transformation of the planned dose distribution (pDD), computed at a given spatial resolution and changing the voxel size to match the CT-voxel size with a tolerance of ±20%. 4. The method according to claim 1 , wherein the CT-scan of the beam shaping device is performed with a CT-voxel size of not more than 0.5 mm. 5. The method according to claim 4 , wherein the planned device design is created from the treatment plan (TP) using a TPS with a voxel size similar to or smaller than the CT-voxel size. 6. The method according to claim 1 , wherein comparing the calculated dose distribution (cDD) with the reference dose distribution (rDD) is performed with a gamma-evaluation and wherein in case a gamma value (γ) lower than or equal to a reference gamma-value (γr) is obtained in a predefined percentage of the voxels of the reference dose distribution (rDD), the beam shaping device is considered as in agreement with the planned device design, wherein γ is defined as a minimum of the following function, γ = min ( ❘ "\[LeftBracketingBar]" d ( c D D ) - d ( rDD ) ❘ "\[RightBracketingBar]" 2 D T A 2 + ❘ "\[LeftBracketingBar]" D ( c D D ) - D ( rDD ) ❘ "\[RightBracketingBar]" 2 Δ D 2 ) ( 1 ) wherein, |d(cDD) −d(rDD)| is a distance between analyzed points, |D(cDD) −D(rDD) | are dose differences, and DTA and AD are scaling factors. 7. The method according to claim 6 , wherein in c
and measuring the absorption · CPC title
by observing the transmission of wave or particle radiation through the material · CPC title
Elements inserted into the radiation path within the system, e.g. filters or wedges · CPC title
for verifying the dose delivered by the treatment plan · CPC title
Treatment planning systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.